ORUDIS E-50 DIN 01926381
Health Canada record
| Active ingredient(s) | KETOPROFEN 50 MG |
|---|---|
| Dosage form | Tablet (Enteric-Coated) |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | M01AE03 KETOPROFEN |
| Original market date | 31-Dec-1983 |
| Current status date | 30-Jul-2004 |
| Source | Health Canada DPD |
Establishment licence of the holder
Aventis Pharma Manufacturing Pte Ltd. — licence , not currently licensed, last inspection rating C (2024-05-09).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing KETOPROFEN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02534606 | FARMAFEN | BIMEDA-MTC ANIMAL HEALTH INC | Solution | KETOPROFEN 100 MG | Marketed |
| 02172577 | KETOPROFEN SR | AA PHARMA INC | Tablet (Extended-Release) | KETOPROFEN 200 MG | Marketed |
| 02446316 | KETOPROFEN V | MODERN VETERINARY THERAPEUTICS LLC | Solution | KETOPROFEN 100 MG | Marketed |
| 00842664 | KETOPROFEN-E | AA PHARMA INC | Tablet (Enteric-Coated) | KETOPROFEN 100 MG | Marketed |
| 00790435 | KETOPROFEN-E | AA PHARMA INC | Tablet (Enteric-Coated) | KETOPROFEN 50 MG | Marketed |
| 02519801 | RIFEN | VETVIVA RICHTER GMBH | Solution | KETOPROFEN 100 MG | Marketed |
| 01938126 | ANAFEN | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Solution | KETOPROFEN 100 MG | Cancelled Post Market |
| 02150999 | ANAFEN INJECTION 10MG/ML | MERIAL CANADA INC | Solution | KETOPROFEN 10 MG | Cancelled Post Market |
| 02150972 | ANAFEN TABLETS 10MG/TAB | MERIAL CANADA INC | Tablet | KETOPROFEN 10 MG | Cancelled Post Market |
| 02150980 | ANAFEN TABLETS 20MG/TAB | MERIAL CANADA INC | Tablet | KETOPROFEN 20 MG | Cancelled Post Market |
| 02150964 | ANAFEN TABLETS 5MG/TAB | MERIAL CANADA INC | Tablet | KETOPROFEN 5 MG | Cancelled Post Market |
| 00790427 | KETOPROFEN | AA PHARMA INC | Capsule | KETOPROFEN 50 MG | Dormant |
| 02237011 | KETOPROFEN SUPPOSITORIES | PHARMEL INC | Suppository | KETOPROFEN 100 MG | Cancelled Post Market |
| 02236965 | KETOPROFEN SUPPOSITORIES | PHARMEL INC | Suppository | KETOPROFEN 50 MG | Cancelled Pre Market |
| 02084198 | KETOPROFEN-E ECT 100MG | PRO DOC LIMITEE | Tablet (Enteric-Coated) | KETOPROFEN 100 MG | Cancelled Post Market |
| 02084171 | KETOPROFEN-E ECT 50MG | PRO DOC LIMITEE | Tablet (Enteric-Coated) | KETOPROFEN 50 MG | Cancelled Post Market |
| 02210487 | KETOPROFEN-SR - SRT 200MG | PRO DOC LIMITEE | Tablet (Extended-Release) | KETOPROFEN 200 MG | Cancelled Post Market |
| 02156083 | NOVO-KETO SUPPOSITORIES 100MG | NOVOPHARM LIMITED | Suppository | KETOPROFEN 100 MG | Cancelled Post Market |
| 01981536 | NOVO-KETO-EC TAB 100MG | NOVOPHARM LIMITED | Tablet (Enteric-Coated) | KETOPROFEN 100 MG | Cancelled Post Market |
| 01981528 | NOVO-KETO-EC TAB 50MG | NOVOPHARM LIMITED | Tablet (Enteric-Coated) | KETOPROFEN 50 MG | Cancelled Post Market |
| 02044633 | NU-KETOPROFEN CAP 50MG | NU-PHARM INC | Capsule | KETOPROFEN 50 MG | Cancelled Post Market |
| 02044641 | NU-KETOPROFEN-E ECT 100MG | NU-PHARM INC | Tablet (Enteric-Coated) | KETOPROFEN 100 MG | Cancelled Post Market |
| 02044781 | NU-KETOPROFEN-E ECT 50MG | NU-PHARM INC | Tablet (Enteric-Coated) | KETOPROFEN 50 MG | Cancelled Post Market |
| 02165481 | ORAFEN - SUP RT 100MG | TECHNILAB PHARMA INC. | Suppository | KETOPROFEN 100 MG | Cancelled Post Market |
| 01926411 | ORUDIS 100 | AVENTIS PHARMA INC | Suppository | KETOPROFEN 100 MG | Cancelled Post Market |
| 01931512 | ORUDIS 50 | AVENTIS PHARMA INC | Suppository | KETOPROFEN 50 MG | Cancelled Post Market |
| 01926403 | ORUDIS CAP 50MG | AVENTIS PHARMA INC | Capsule | KETOPROFEN 50 MG | Cancelled Post Market |
| 01926365 | ORUDIS E-100 | AVENTIS PHARMA INC | Tablet (Enteric-Coated) | KETOPROFEN 100 MG | Cancelled Post Market |
| 01926373 | ORUDIS SR-200 | AVENTIS PHARMA INC | Tablet (Extended-Release) | KETOPROFEN 200 MG | Cancelled Post Market |
| 01913050 | ORUVAIL 150 | AVENTIS PHARMA INC | Capsule (Sustained-Release) | KETOPROFEN 150 MG | Cancelled Post Market |
| 01913069 | ORUVAIL 200 | AVENTIS PHARMA INC | Capsule (Sustained-Release) | KETOPROFEN 200 MG | Cancelled Post Market |
| 02015951 | PMS-KETOPROFEN | PHARMASCIENCE INC | Suppository | KETOPROFEN 100 MG | Cancelled Post Market |
| 02148773 | PMS-KETOPROFEN | PHARMASCIENCE INC | Suppository | KETOPROFEN 50 MG | Cancelled Post Market |
| 02150808 | PMS-KETOPROFEN CAPSULES | PHARMASCIENCE INC | Capsule | KETOPROFEN 50 MG | Cancelled Post Market |
| 02150824 | PMS-KETOPROFEN E-100 - ECT | PHARMASCIENCE INC | Tablet (Enteric-Coated) | KETOPROFEN 100 MG | Cancelled Post Market |
| 02150816 | PMS-KETOPROFEN E-50 - ECT 50MG | PHARMASCIENCE INC | Tablet (Enteric-Coated) | KETOPROFEN 50 MG | Cancelled Post Market |
| 00761699 | RHODIS | SANOFI-AVENTIS CANADA INC | Suppository | KETOPROFEN 100 MG | Cancelled Post Market |
| 00761664 | RHODIS CAP 50MG | RHODIAPHARM INC | Capsule | KETOPROFEN 50 MG | Cancelled Post Market |
| 00761680 | RHODIS EC | SANOFI-AVENTIS CANADA INC | Tablet (Enteric-Coated) | KETOPROFEN 100 MG | Cancelled Post Market |
| 00761672 | RHODIS EC | SANOFI-AVENTIS CANADA INC | Tablet (Enteric-Coated) | KETOPROFEN 50 MG | Cancelled Post Market |
| 02031175 | RHODIS SR 200MG | RHODIAPHARM INC | Tablet (Extended-Release) | KETOPROFEN 200 MG | Cancelled Post Market |
| 02183099 | RHOVAIL 150 | RHODIAPHARM INC | Capsule (Sustained-Release) | KETOPROFEN 150 MG | Cancelled Post Market |
| 02183102 | RHOVAIL 200 | RHODIAPHARM INC | Capsule (Sustained-Release) | KETOPROFEN 200 MG | Cancelled Post Market |
| 02245967 | TEVA-KETOPROFEN | TEVA CANADA LIMITED | Tablet | KETOPROFEN 20 MG | Cancelled Post Market |
| 02245966 | TEVA-KETOPROFEN | TEVA CANADA LIMITED | Tablet | KETOPROFEN 5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 1236 | 2000-12-11 | New Drug Submission (NDS) |
International API supply for KETOPROFEN
10 valid EDQM Certificates of Suitability from 10 holders. 10 active FDA Drug Master Files.
Request a quote for ORUDIS E-50